Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could spot 8 cancers early using AI

NCT ID NCT06717295

Recruiting now Diagnosis Sponsor: Javier Toledo Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new AI-powered blood test that looks at platelets and immune cells to find early signs of eight different cancers, including lung, breast, and pancreatic cancer. Researchers will collect blood samples from 6,000 adults aged 40 and older, both with and without cancer, to see if the test can accurately tell them apart. The goal is to create a non-invasive way to catch cancer early and track how well treatments are working.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
DiNanoQ blood test and DiNanoTrack blood test
What this could lead to
If successful, this could lead to a simple blood test that catches several cancers early and helps doctors see if treatment is working.
What could go wrong
This is an early observational study, not a treatment trial. The test may not be accurate enough for widespread use, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer carcinoma of liver and intrahepatic biliary tract colorectal cancer colorectal neoplasm glioblastoma glioma susceptibility 1 hepatocellular carcinoma lung cancer lung neoplasm malignant pancreatic neoplasm neoplasm non-small cell lung carcinoma ovarian cancer Pancreatic cancer, adult prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREST CANCER COLORECTAL CANCER GLIOBLASTOMA (GBM) LIVER CARCINOMA LUNG CANCER (NSCLC) OVARIAN CANCER PANCREATIC CANCER, ADULT PROSTATE CANCERS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Babraham Research Institute

    ENROLLING_BY_INVITATION

    Cambridge, CB22 3AT, United Kingdom

  • Dysplasia Diagnostics Limited

    RECRUITING

    London, W1W 7LT, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NSIA- Lagos University Teaching Hospital Cancer Centre

    RECRUITING

    Lagos, Nigeria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • Various Cancer Centres

    ACTIVE_NOT_RECRUITING

    Rosario, Argentina

More trials for these conditions

Other studies related to the condition(s) this trial covers.